ArticleBMC cancer2023

Protocol for the 2ND-STEP study, Japan Clinical Oncology Group study JCOG1802: a randomized phase II trial of second-line treatment for advanced soft tissue sarcoma comparing trabectedin, eribulin and pazopanib.

Makoto Endo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.